rs1800764 — ACE Promoter T>C

ACE Promoter Variant — A Third Layer of Cardiovascular Regulation

The angiotensin-converting enzyme¹¹ angiotensin-converting enzyme
ACE cleaves angiotensin I into angiotensin II (a potent vasoconstrictor) and inactivates bradykinin (a vasodilator); it governs blood pressure, vascular tone, and fluid balance through the renin-angiotensin-aldosterone system (RAAS) gene harbours more genetic variation than its most famous variant — the intron 16 insertion/deletion — would suggest. The GeneOps database already profiles two ACE variants: rs4341²² rs4341 (the I/D tag SNP) and rs1799752³³ rs1799752 (the causal I/D structural variant). rs1800764 is a distinct third site: a C/T single-nucleotide change upstream of the ACE promoter, residing on a separate linkage disequilibrium block⁴⁴ linkage disequilibrium block
A stretch of DNA in which alleles tend to be inherited together without much recombination separating them; variants on different LD blocks can be partially correlated but carry independent information from the I/D locus.

Unlike the I/D polymorphism — which modulates ACE enzyme activity directly and has been extensively studied in athletic cohorts — rs1800764's documented effects are cardiovascular and renal. It sits at the regulatory end of the gene, near the promoter, and its associations point toward hypertension susceptibility and kidney disease risk rather than the endurance-versus-power axis captured by the I/D.

The Mechanism

rs1800764 sits upstream of the ACE transcription start site in a region enriched for transcription factor binding sites⁵⁵ transcription factor binding sites
Regulatory DNA sequences recognised by transcription factors, proteins that control how actively a gene is read into mRNA; changes in these sequences can increase or decrease baseline gene expression without altering the protein's amino acid sequence. The variant is classified as regulatory — it changes a single nucleotide in the 5'-flanking region rather than altering the ACE protein sequence.

A fine-mapping study of 31 ACE SNPs⁶⁶ fine-mapping study of 31 ACE SNPs
Chung C-M et al. Fine-mapping angiotensin-converting enzyme gene: separate QTLs identified for hypertension and for ACE activity. PLoS One, 2013 in 1,168 individuals from 305 young-onset hypertension pedigrees revealed four LD blocks across the ACE gene. rs1800764 occupies LD block 2 in the promoter region; the I/D polymorphism in intron 16 and the two major ACE enzyme activity QTLs⁷⁷ QTLs
Quantitative trait loci — chromosomal regions where genetic variation predicts a measurable trait like enzyme activity or blood pressure lie on downstream LD blocks spanning exon 13–intron 18 and intron 20–3'UTR. This architecture means the promoter variant and the I/D exist on independently segregating haplotypes: one governs transcriptional regulation and hypertension susceptibility, the other governs enzyme activity and athletic performance adaptation.

A complementary piece of evidence comes from a luciferase reporter assay in Korean asthmatics⁸⁸ luciferase reporter assay in Korean asthmatics
Kim S-H et al. Association of angiotensin I-converting enzyme gene polymorphisms with aspirin intolerance in asthmatics. Clin Exp Allergy, 2008 examining a nearby ACE promoter polymorphism at position -262: this closely adjacent promoter variant showed measurably lower promoter-driven transcription compared to the common allele. While the -262 position may not be identical to rs1800764 (their exact relationship requires full-text comparison), the functional data confirm that promoter-region ACE variation does modulate transcriptional output and is not merely a neutral tag.

The Evidence

The strongest independent evidence for rs1800764 comes from a DCCT/EDIC nephropathy genetics study⁹⁹ DCCT/EDIC nephropathy genetics study
Costacou T et al. Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes. Diabetes, 2005 of 1,365 type 1 diabetic subjects. The investigators used three-marker haplotype analysis spanning rs1800764, the I/D polymorphism, and rs9896208 to capture common ACE haplotypes in Caucasians. The haplotype carrying the T allele at rs1800764, the insertion allele, and C at rs9896208 (designated TIC) was associated with significantly lower risk of persistent microalbuminuria (HR 0.49, 95% CI 0.32–0.75, p=0.0009) and severe nephropathy (HR 0.41, 95% CI 0.22–0.78, p=0.006) compared to the reference CDT haplotype. This haplotype analysis suggests that T at rs1800764 tags a protective regulatory configuration — one that includes the insertion allele but may confer protection beyond what the I/D alone predicts.

For hypertension, the Chung et al. 2013 fine-mapping study found rs1800764 significantly associated with young-onset hypertension¹⁰¹⁰ young-onset hypertension
Hypertension presenting before age 40 is more likely to have a monogenic or strong polygenic genetic contribution than late-onset hypertension, making genetic studies of young-onset cases particularly informative for identifying causal variants (p=0.04) in a Taiwanese pedigree cohort, with replication in 842 independent subjects. The association was specific to the promoter LD block and was distinct from the ACE activity associations in downstream LD blocks.

An analysis of Tunisian type 2 diabetic patients¹¹¹¹ analysis of Tunisian type 2 diabetic patients
Ezzidi I et al. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy. Diabetes Metab Res Rev, 2009 found higher rs1800764 minor allele frequency in diabetic nephropathy patients versus controls, and identified multiple three-locus haplotypes (rs1799752/rs1800764/rs12449782) independently modulating nephropathy risk — further evidence that the promoter variant contributes information beyond the I/D polymorphism alone.

In Alzheimer's disease research, rs1800764 findings have been inconsistent: a Chinese population study found significant allele frequency differences between patients and controls, while a large multicenter Caucasian analysis found no association. These contradictory results likely reflect population-specific LD patterns — the African population carries C at >83% frequency, making the variant much less informative as a risk tag in African-ancestry cohorts.

Practical Implications

For most users, rs1800764 provides a supplementary cardiovascular signal that complements — but does not replace — the I/D genotype. The C allele at this promoter site is associated with hypertension susceptibility, and CC carriers benefit from the same cardiovascular monitoring approach as I/D DD individuals: blood pressure tracking, routine cardiovascular assessment, and awareness of elevated RAAS tone.

The absence of athletic performance data means this variant does not change the endurance-versus-power framing established by the I/D. A person carrying both the insertion allele (endurance-favoring on rs4341/rs1799752) and the C allele at rs1800764 holds a somewhat contradictory profile: lower ACE enzyme activity from the insertion, but a promoter configuration associated with hypertension susceptibility. Whether this combination carries additive cardiovascular risk is not established by current literature.

Interactions

The ACE promoter variant is embedded in a broader ACE haplotype context. rs4341¹²¹² rs4341 (C/G tag for insertion/deletion) and rs1799752¹³¹³ rs1799752 (the causal I/D structural variant) capture the enzyme-activity dimension; rs1800764 captures a distinct promoter-region dimension. They are partially correlated — the T allele of rs1800764 co-travels with the insertion (C) allele of rs4341 in the H2 haplotype identified in Korean warfarin patients — but they are not redundant. Both carry independent clinical signal.

The AGTR1 A1166C variant (rs5186)¹⁴¹⁴ AGTR1 A1166C variant (rs5186) encodes the angiotensin II type 1 receptor. In individuals who carry both the ACE C allele (higher ACE-driven angiotensin II production) and the AGTR1 C allele (more responsive AT1 receptor), angiotensin II signalling is amplified at both ligand production and receptor sensitivity levels. This combination is relevant to cardiovascular risk assessment and should prompt more vigilant blood pressure monitoring.

rs4291¹⁵¹⁵ rs4291, a promoter-region ACE variant ~600 bp upstream, has been studied in Alzheimer's disease contexts alongside rs1800764. These two promoter SNPs may tag partially overlapping or adjacent regulatory elements within the same ACE promoter LD block.